Related Experiment Videos
[Primary malignant lymphoma of the testis]
M Stein1, N Haim, M Ben-Shahar
1Northern Israel Oncology Center and Dept. of Pathology, Rambam Medical Center, Haifa.
Harefuah
|February 1, 1991
Summary
Primary testicular lymphoma is a rare cancer. Aggressive chemotherapy offers potential cure for this aggressive non-Hodgkin
Area of Science:
- Oncology
- Hematology
- Pathology
Context:
- Primary testicular lymphoma is a rare extranodal non-Hodgkin's lymphoma.
- Observed in 7 out of 715 patients (0.9%) referred to an oncology center between 1973-1989.
- Typically presents as testicular mass or swelling in middle-aged men (mean age 55).
Purpose:
- To analyze the clinical characteristics, treatment, and outcomes of primary testicular lymphoma.
- To evaluate the efficacy of chemotherapy and radiotherapy in managing this condition.
Summary:
- All 7 patients had diffuse large cell type lymphoma, with stages IE, IIE, or IVE.
- Most underwent inguinal orchiectomy and received chemotherapy.
- Outcomes varied, with 3 patients experiencing recurrence and death, while 3 remain disease-free.
Impact:
- Primary testicular lymphoma shows a tendency for early systemic progression.
- Aggressive combination chemotherapy demonstrates potential curability.
- Highlights the importance of prompt diagnosis and treatment for improved patient survival.